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Abstract
Deoxyribose-5-phosphate aldolases (DERAs, EC 4.1.2.4) are acetaldehyde-dependent, Class I aldolases catalyzing in nature a
reversible aldol reaction between an acetaldehyde donor (C2 compound) and glyceraldehyde-3-phosphate acceptor (C3 com-
pound, C3P) to generate deoxyribose-5-phosphate (C5 compound, DR5P). DERA enzymes have been found to accept also other
types of aldehydes as their donor, and in particular as acceptor molecules. Consequently, DERA enzymes can be applied in C–C
bond formation reactions to produce novel compounds, thus offering a versatile biocatalytic alternative for synthesis. DERA
enzymes, found in all kingdoms of life, share a common TIM barrel fold despite the low overall sequence identity. The catalytic
mechanism is well-studied and involves formation of a covalent enzyme-substrate intermediate. A number of protein engineering
studies to optimize substrate specificity, enzyme efficiency, and stability of DERA aldolases have been published. These have
employed various engineering strategies including structure-based design, directed evolution, and recently also machine
learning–guided protein engineering. For application purposes, enzyme immobilization and usage of whole cell catalysis are
preferred methods as they improve the overall performance of the biocatalytic processes, including often also the stability of the
enzyme. Besides single-step enzymatic reactions, DERA aldolases have also been applied in multi-enzyme cascade reactions
both in vitro and in vivo. The DERA-based applications range from synthesis of commodity chemicals and flavours to more
complicated and high-value pharmaceutical compounds.
Key points
• DERA aldolases are versatile biocatalysts able to make new C–C bonds.
• Synthetic utility of DERAs has been improved by protein engineering approaches.
• Computational methods are expected to speed up the future DERA engineering efforts.
Keywords DERA . Aldolase . Protein engineering . C–C bond formation . Biocatalysis . Applications
Introduction
Enzymatic C–C bond formation reactions offer a means to
build up the carbon backbone and synthesize important
organic compounds. The C–C bond forming reactions
can be catalyzed by enzymes belonging to various EC
classes, such as lyases, oxidoreductases, and transferases.
The most well-known and studied reactions are catalyzed
by a ldo lases (EC 4.1 .2 , be long ing to lyases ) ,
transketolases (EC 2.2.1, belonging to transferases), and
pyruvate decarboxylases (EC 4.1.1.1, belonging to ly-
ases). The latter two enzyme families utilize thiamine di-
phosphate as a cofactor. In addition, decarboxylation ren-
ders to overall reaction irreversible that might be useful in
increasing the reaction yield (Resch et al. 2011; Fesko and
Gruber-Khadjawi 2013). The use of various aldolases in
stereoselective synthesis and their engineering has been
recently reviewed (Clapés et al. 2010; Windle et al.
2014). The current review focuses in particular on 2-
deoxyribose-5-phosphate aldolases (DERA, EC 4.1.2.4),
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which are widespread cytosolic enzymes involved in the
catabolism of the pentose motif of deoxynucleosides in
the pentose phosphate pathway and do not require any
cofactor for their activity (Tozzi et al. 2006).
Aldolases, in general, catalyze the reversible formation of
C–C bonds by the aldol addition of a nucleophilic donor, for
example a ketone enolate, onto an electrophilic aldehyde ac-
ceptor (Fig. 1A). DERA enzymes belong to so called Class I
aldolases and catalyze a reaction for which both of the sub-
strates and the product are aldehydes, i.e. the reaction between
2-deoxy-D- r ibose -5 -phospha t e (DR5P) and D-
glyceraldehyde-3-phosphate (G3P) + acetaldehyde (C2)
(Fig. 1B). In this reversible reaction, C–C bond is either
cleaved (retroaldol reaction) or formed (aldol reaction) (Fig.
1A). Class I aldolases form with the donor substrate a Schiff
base (an imine), which is in equilibrium with enamine form
and able to react with the acceptor aldehyde (Fig. 2).
DERA enzymes are promiscuous and able to accept a wide
range of non-natural aldehydes as acceptor molecules, thus
offering a biocatalytic alternative for a (stereo)selective
synthesis of C–C bonds, as shown for example by Liu and
Wong (2002). Donor substrate specificity is stricter; however,
there are studies demonstrating that some DERA enzymes
also possess nucleophile substrate promiscuity (Barbas et al.
1990; Hernández et al. 2018; Chambre et al. 2019).
Furthermore, DERA enzymes can use acetaldehyde as sole
substrate, leading in a tandem reaction to formation of a C6
product, 2,4,6-trideoxyhexose (Fig. 1D–E), which is cyclized
spontaneously and can be removed from the reaction (Gijsen
and Wong 1994). In an aldol addition step, catalyzed by
DERA, a new stereogenic center is formed (Fig. 1A). It should
also be noted that reaction products of DERA are also alde-
hydes, and these can be readily subjected to further addition
reactions leading to increasingly complex structures. DERA
enzymes have been used to synthesize commodity chemicals
like pentaerythritol (a building block, e.g. for the synthesis of
explosives, plastics, paints, and cosmetics), deoxysugars, fla-
vours, and complex pharmaceutical molecules. The latter in-
clude antitumor agent epothilone A, and investigational
Islatravir drug for HIV treatment. DERA-based processes
Fig. 1 Chemical reactions catalyzed by DERA. (A) A general aldol
reaction in which the carbonyl compound donor makes a covalent bond
(in red) with the carbonyl compound acceptor. Depending on the donor,
there is a possibility for formation of a new stereogenic center (*) in the
product. (B) A reversible aldol reaction catalyzed in Nature by DERA, a
Class I aldolase, between an acetaldehyde donor (C2 compound) and
glyceraldehyde-3-phosphate acceptor (C3 compound, G3P) to generate
deoxyribose-5-phosphate, DR5P (C5 compound) which forms a furanose
isomer. (C) DERA-catalyzed reaction between acetaldehyde and a non-
phosphorylated glyceraldehyde produces D-2-deoxyribose (DR), which
is able to form furanose and pyranose isomers. (D) The reaction of two
acetaldehydes, catalyzed by DERA, produces crotonaldehyde. (E)
Crotonaldehyde can react further with a third acetaldehyde molecule in
a DERA-catalyzed reaction, to produce 3,5-dihydroxyhexanal, which
cyclizes to a more stable pyranose form
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have also been developed for the synthesis of side chain of
statin-type cholesterol-lowering drugs (i.e. atorvastatin and
rosuvastatin) by DSM Pharma Chemicals, Diversa and Lek
Pharmaceuticals. The biocatalytic applications of DERA have
been recently extensively reviewed (Bolt et al. 2008; Fei et al.
2017; Haridas et al. 2018)
The use of DERA enzymes would thus offer great potential
in manufacturing various chemicals (Fei et al. 2017; Haridas
et al. 2018). One of the major challenges in using naturally
occurring DERA enzymes in industrial processes, in which
high substrate loads are needed to reach the desired produc-
tivity, is the high inactivation of the enzyme in the presence of
aldehydes. In addition, the catalytic efficiency on non-natural
substrates is often considerably lower as compared to the nat-
ural substrates. Furthermore, if the acceptor and donor sub-
strate ranges could be further broadened or shifted, this would
also expand the application potential of DERA aldolases.
Protein engineering offers a means to affect the enzyme prop-
erties, such as substrate promiscuity and catalytic rate, to op-
timize or invert stereoselectivity, and to improve stability un-
der certain conditions or release inhibition. Recent develop-
ments in this field concerning DERA aldolases are the scope
of this review.
Sequence and structural information of DERA
enzymes
DERA aldolases are ubiquitous enzymes found in all king-
doms of life including fungi, bacteria, archaea, and higher
eukaryotes, as well as psychrophilic and hyperthermophilic
organisms. As explained in more details below, DERA en-
zymes share a common TIM barrel fold. In a phylogenetic
analysis of approximately 2500 DERA sequences, obtained
from the KEGG Orthology database using the KO identifier
for Escherichia coli DERA, Kim et al. found that DERA en-
zymes are clustered into five major groups (Kim et al. 2020).
The different groups included sequences from bacteria,
Firmicutes (Bacilli and Clostridia), Proteobacteria (including
E. coli DERA), and two groups with sequences from mixed
domains.
The 3D structures of several DERA enzymes have been
solved, and there are also some complex structures available.
These have revealed that despite relatively low sequence iden-
tity, all DERAs have a TIM (α/β)8-barrel fold where the cat-
alytic amino acids as well as other amino acid residues around
the active site seem to be relatively well conserved (Heine
2001; Haridas et al. 2018). DERA enzymes usually have a
quaternary structure, which in the reported cases is either a
dimer or tetramer (Dick et al. 2016b). DERA aldolases de-
rived from psychrophilic and mesophilic organisms seem to
have dimeric structure, whereas those from hyperthermophilic
have tetrameric structure. Moreover, the dimer interface for
psyhcrophilic and mesophilic DERAs seem similar.
Hydrophobic clusters within the dimer interfaces are sug-
gested to contribute to the overall thermostability of tetrameric
DERAs from thermophilic bacterium Thermus thermophilus
and hyperthermophilic archaeon Aeropyrum pernix (Sakuraba
et al. 2003; Lokanath et al. 2004). In general, the thermosta-
bilities of DERA enzymes seem to vary for reasons that are
not self-evident. As an example, DERA derived fromE. coli, a
mesophilic bacterium, is relatively thermostable, having the
Fig. 2 Main phases in the
reaction mechanism of DERA-
catalyzed aldol reaction. (A) The
donor aldehyde makes a covalent
bond with nucleophilic Lysine
(Lys167 in E. coli DERA) of the
enzyme, forming an enamine (in
equilibrium with imine, the Schiff
base). This enamine forming
phase includes several
intermediates. (B) Reaction of the
enamine with the protonated
acceptor aldehyde produces an
aldol, covalently attached to the
Lysine. (C) Release of aldol. This
phase also includes several
intermediates. The key catalytic
residue is Lysine which make a
covalent bond with the donor
aldehyde. In addition, there are
other residues in the active site
which promote the reaction
participating in protonation and
deprotonation of intermediates
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measured melting temperature (Tm) of 65 °C (Voutilainen
et al. 2020).
The first solved crystal structure of DERA was that from
E. coli (Heine 2001; Heine et al. 2004). It is also themost well-
studied and applied DERA enzyme so far. The polypeptide
chain of E. coli DERA consists of 259 amino acid residues;
however, the crystal structure did not contain the last eight
residues at C-terminus, probably due to existence of multiple
conformations. It has been shown by NMR spectroscopy that
this tail exists indeed in two major conformations and the C-
terminal Tyrosine participates also in catalysis (Schulte et al.
2017; Schulte et al. 2018). The E. coliDERA crystal structure
showed the formation of a symmetric dimer. The moderate
monomer-monomer interface (444 Å2), however, suggests
that enzyme exists as a mixture of monomer and dimer in
solution. The monomer of DERA contains one eight-
stranded α/β-barrel and the active site is located at the C-
terminal region of the parallel β-sheet barrel. According to
the complex structures and mutagenesis studies, it was de-
duced that Lys167 is a key catalytic residue making a covalent
bond with donor aldehyde (Heine 2001). Asp102 and Lys201
are also important for the reaction course participating in pro-
tonation and deprotonation of reaction intermediates (Heine
2001). Cys47 seems not to be essential for catalysis but its
reaction with reaction products or intermediates may lead to
enzyme inactivation (Heine 2001; Dick et al. 2016a; Bramski
et al. 2017) (Fig. 3).
In the substrate-binding pocket of DERA, the donor acet-
aldehyde binds to the bottom and the acceptor G3P (glyceral-
dehyde-3-phosphate) to the upper part of the pocket. Binding
of the substrates is mediated through hydrogen bonds, either
directly or through water molecules. The substrate-binding
site of DERA is highly preferential for the phosphorylated
acceptor substrate, G3P, which is illustrated by the drastic loss
of activity when comparing G3P and D-glyceraldehyde as
acceptor substrates (Table 1). Themain residues for phosphate
binding in E. coli DERA are Lys172 (via a bridging water
molecule), Ser238, and Gly205, and water bridge interactions
with the backbone moieties of Gly171, Val206, Gly236, and
Ser239.
The determination of 3D structures of DERA initiated pro-
tein engineering studies in order to improve catalytic efficien-
cy and to develop DERA-based variants for catalysis of aldol
reactions for various substrates.
Kinetic properties and substrate promiscuity
of DERA wild-type enzymes
DERA is currently the only member of the acetaldehyde-
dependent Class I aldolases, and more generally, it is one of
the only two known aldolases, fructose-6-phosphate aldolase
being the other, that are able to catalyze aldol reactions be-
tween two aldehydes (Garrabou et al. 2009; Chambre et al.
2019). The Class I aldolases do not require any cofactor (un-
like Class II aldolases) but exhibit a conserved Lysine residue
in the active site. In E. coli, DERA-catalyzed reaction acetal-
dehyde (donor substrate) forms a covalent Schiff base inter-
mediate with the active site Lys167 (Heine 2001), and its
enamine tautomer corresponds to the enolic donor in aldol
reaction (Fig. 2A). The electrophilic acceptor substrate of
DERA is G3P. The product from the DERA-catalyzed aldol
addition reaction, DR5P, can exist as linear aldehyde isomer
and as cyclic furanose isomer in solution. The covalent bond
formation with Lys167 of E. coli DERA is only possible with
linear isomer of DR5P. On the other hand, the chemical equi-
librium of the reaction favours the formation of DR5P in so-
lution because of the stability of cyclic furanose form of DR5P
over the linear form (Fig 1B). The equilibrium constant K of
this aldol reaction (Fig. 1B) has been reported to be 5000M−1
for Lactobacillus plantarum DERA (Pricer and Horecker
1960).
Detailed kinetic data have been reported only for a limited
number of DERA-catalyzed reactions and include mainly data
for retroaldol reaction in which DR5P or DR (D-2-deoxyri-
bose) has been used as a substrate (Fig. 1B–C) (Table 1).
DERA is an efficient enzyme when DR5P is used as a sub-
strate although the conversion from cyclic furanose form to
linear aldehyde form may affect the kinetics. The catalytic
efficiency (kcat/Km) for DR is significantly lower due to the
Fig. 3 (A) The 3D structure of
monomeric DERA from E. coli.
(B) The active site of E. coli
DERA with the covalently bound
carbinolamine intermediate (in
cyan) (PDB 1JCL). Key catalytic
residues are presented as green
sticks. The positions of four
mutations described in the review
are presented as grey sticks
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weaker substrate binding, which can be seen in much higher
(roughly 100-fold in the case of E. coli DERA) Km values as
compared to that of DR5P (Table 1). DR does not have the
phosphate group which seems, thus, to be important for tighter
binding. As can be seen from Table 1, the turnover number
(kcat) is also much smaller for DR.
DERA aldolases were discovered in 1950s (Racker 1952),
and soon the potential of DERA as a tool for enzyme-
mediated C–C bond formation between acetaldehyde and var-
ious non-natural acceptor substrates became evident (Rosen
et al. 1965). Barbas and coworkers (Barbas et al. 1990)
showed that with regard to the specificity of acceptors, many
aldehydes as well as aldose sugars (e.g. glucose, arabinose,
ribose, and N-acetylglucosamine) and their phosphates are
accepted as weak substrates. The catalytic efficiency was
shown in each case to be up to several orders of magnitude
lower towards these types of non-natural acceptor substrates
(Chen et al. 1992). Furthermore, it was demonstrated that
besides acetaldehyde, DERA can accept propionaldehyde as
well as also two ketones, acetone and fluoroacetone, as weak
donor substrates. A recent screening of over 300 different
DERA sequences, selected from the UniProt database and
heterologously expressed in E. coli, further revealed that some
microbial DERA enzymes can indeed display also remarkable
donor substrate promiscuity (Hernández et al. 2018; Chambre
et al. 2019). As mentioned earlier, DERA enzymes are addi-
tionally able to catalyze tandem aldol addition of acetaldehyde
molecules, in which the aldehyde product from the first aldol
addition is used as acceptor substrate in the second reaction
(Gijsen andWong 1994). The coupling of three acetaldehydes
produces a stable cyclic hexapyranose (Fig. 1D–E), which
offers routes for stereospecific manufacturing of cyclic com-
pounds. Sakuraba and coworkers (Sakuraba et al. 2007) have
demonstrated that hyperthermophilic DERAs from
P. aerophilum and T. maritima are much more efficient in
the production of cyclic hexapyranose compared to E. coli
DERA, but interestingly in the synthesis of DRP, E. coli
DERA was more efficient. In addition, Greenberg et al.
(2004) screened successfully from large metagenomic librar-
ies DERA enzymes that have a better tolerance to high sub-
strate concentrations and allow reduced usage of catalyst in
production of 6-carbon precursor of statin drugs.
Protein engineering of DERA
Protein engineering to optimize the enzyme properties, such
as substrate specificity or activity and/or stability under oper-
ational conditions, has classically relied either on rational de-
sign, based on solved 3D structures (or good 3D models) of
the enzymes, or on using directed evolution without the ne-
cessity of any structural information. Directed evolution iter-
atively evolves an enzyme towards the defined goal by creat-
ing large genetic variation to the starting wild-type enzyme
sequence (Stemmer 1994; Arnold 2018). Different mutagen-
esis approaches can be utilized to create these enzyme variant
libraries: random mutagenesis, saturation mutagenesis, and/or
DNA shuffling (through recombination). Selection, or more
often due to practical reasons, screening of variant libraries is
used as a means to identify improved enzyme candidates, and
usually further rounds of sequence diversification are needed
to achieve the desired enzyme properties. Screening can be
carried out in various manners using either the desired target
substrates or model substrates, such as fluorogenic substrates
to aid the assaying (Jourdain et al. 1998; Greenberg et al.
2004; Fei et al. 2015).
Directed evolution is a powerful way to optimize the en-
zyme properties towards application requirements. However,
as the screening, even if carried out in an automated high-
throughput manner, may be very time-consuming and costly,
computational methods and/or structural information of the
enzymes are being more and more incorporated into directed
evolution approaches to create targeted (focused) enzyme
Table 1 Reported kinetics for
retroaldol reactions by wild-type
DERA from different organisms
(the sources which contained kcat/
Km values were selected)
Organism Substrate Km [mM] kcat [1/s] kcat/Km [1/(s•mM)] Reference
E. coli DR5P 0.64 68 106 Heine (2001)
E. coli DR5P 0.64 68 106 DeSantis et al. (2003)
E. coli DR5P 0.29 40 135 Kullartz and Pietruszka (2012)
E. coli DR5P 0.29 33 115 Bisterfeld et al. (2016)
R. erythropolis DR5P 4.84 18 4 Kullartz and Pietruszka (2012)
B. halodurans DR5P 0.22 13 60 Kim et al. (2020)
P. atrosepticum DR5P 0.22 8,5 39 Haridas et al. (2020)
E. coli DR 57 0,1 0.002 DeSantis et al. (2003)
E. coli DR 54 0,2 0.004 Kullartz and Pietruszka (2012)
R. erythropolis DR 418 1,2 0.003 Kullartz and Pietruszka (2012)
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variant libraries (Powell et al. 2001; Reetz 2013; Yang et al.
2014; Arnold 2018).
DERA properties, which have been engineered, include sub-
strate specificity or preference, decreased inhibition by acetalde-
hyde, and altered stereoselectivity. We give examples below on
these rational design and directed evolution efforts that have been
used (see also Table 2). A separate section is also dedicated to
machine learning methods utilized to engineer DERA. Most of
the DERA-based applications utilize one-step enzymatic reac-
tion, but there are also exampleswhereDERA-catalyzed reaction
is a part of multi-enzyme reaction cascade.
Structure-based design
By using the crystal structure of E. coliDERA, DeSantis et al.
designed five single mutations in the active site to improve
retroaldol reaction with DR, the non-phosphorylated deriva-
tive of natural substrate, DR5P (DeSantis et al. 2003). In the
E. coli DERA complex crystal structure, Ser238 forms a hy-
drogen bond with phosphate of the bound DR5P (Fig. 3B). In
line with the structural data, the Ser238Asp mutation showed
2.5-fold improvement in retroaldol reaction with DR when
compared to the wild-type enzyme. The mutated enzyme
was also having clearly (over 100-fold) reduced activity (kcat)
on DR5P. Interestingly, the mutant enzyme was more potent
compared to the wild- type enzyme for using 3-
azidopropinaldehyde as an acceptor in a sequential aldol reac-
tion to form a deoxy-azidoethyl pyranose, which can be used
in synthesis of cholesterol-lowering drugs such as atorvastatin
(Liu et al. 2004). The importance of Ser239 for the binding of
the phosphate group of DR5P has also been demonstrated
with the Ser239Pro mutation resulting in clearly reduced K
m
value while not affecting the catalytic rate (kcat) of E. coli
DERA enzyme (Ma et al. 2016).
It is also worth noting that in the above-mentioned work by
DeSantis et al., in vivo selection system to improve the substrate
specificity of DERA was utilized (DeSantis et al. 2003). The
chosen selection strategy coupled the enzyme activity to growth,
which is a very efficient selection principle allowing large
amounts of enzyme variants (up to 1010–1013) to be examined
(Boersma et al. 2007). In the study, an engineered E. coli
SELECT strain requiring acetaldehyde for growth was utilized.
The E. coli SELECT strain transformed with a plasmid encoding
for wild-type DERA enzyme was able to grow when the cells
were cultivated on minimal medium supplemented with 2-
deoxy-D-ribose 5-phosphate (DR5P), but not if the medium
was supplemented with the non-phosphorylated substrate D-2-
deoxyribose (DR). On the other hand, if E. coli SELECT cells
were transformed with DERA variants exhibiting high retroaldol
activity on DR (thus providing acetaldehyde needed for growth),
the positive transformants would grow in medium supplied with
only DR as a substrate (DeSantis et al. 2003). This latter system
would thus allow discovery of completely new DERA variants
with improved activity on non-phosphorylated or other non-
natural substrates.
Li and coworkers have engineered Klebsiella pneumoniae
DERA for synthesis of 2-deoxycarbohydrates (Li et al. 2015).
They used 3D structural model of the enzyme and information
from the literature to create a number of variants. The goal was
to increase affinity towards non-phosphorylated substrates
and tolerance to higher aldehyde substrate concentrations.
Aldose reac t ion by us ing ace ta ldehyde and D-
glyceraldehyde to produce DR was used to characterize the
mutants. The variant KDERAK12 (i.e. K. pneumoniae DERA
havingmutations Ser238Asp/Phe200Ile/ΔTyr259) showed 3-
fold improvement in specific enzyme activity in this reaction
as compared to the DERA wild-type and 4-fold improvement
as compared to the E. coli DERA. The substrate tolerance
towards aldehyde substrates also increased by 1.5-fold. The
authors discuss how to rationalize these results. The Ser238
residue forms a hydrogen bond with phosphate group and its
mutation modifies substrate specificity towards non-
phosphorylated substrates (Fig. 3B). Phe200 is located in the
β-strand in the active site but not directly interacting with the
substrate (Fig. 3B). Its modification may slightly alter the
shape of the active site. Tyr259 is located at C-terminus of
the protein and recently it has been reported that this tyrosine
could actually enter to the active site in a closed state confor-
mation of DERA (Schulte et al. 2018).
Despite the fact that DERA enzymes utilize acetalde-
hyde as a substrate, acetaldehyde is known to be inhibi-
tory at high concentrations required in applications. Dick
and coworkers have investigated the mechanism of deac-
tivation and suggested that the product of aldol addition
between two acetaldehyde molecules, 3-hydroxybutanal,
is prone to water elimination leading to formation of
crotonaldehyde, which is then able to covalently crosslink
catalytic Lys167 and Cys47 in the active site (Dick et al.
2016a). This observation led Bramski et al. to prepare
seven E. coli DERA variants in which Cys47 was mutated
to Methione, Serine, Threonine, Leucine, Isoleucine,
Alanine, or Glycine (Bramski et al. 2017). The stability
of each variant against acetaldehyde and crotonaldehyde
was tested together with the specific activity in retroaldol
reaction by using DR5P as substrate. E. coli DERA
Cys47Leu mutation was found to be the most effective,
having 30-fold increased half-life for crotonaldehyde and
15-fold for acetaldehyde. However, specific activity for
DR5P retroaldol reaction decreased by 23-fold. Haridas
and coworkers (Haridas et al. 2020) have also recently
improved the acetaldehyde tolerance of Pectobacterium
atrosepticum DERA by creating a Cys49Met mutation.
It is worth noting that P. atrosepticum DERA has an op-
timum pH in the alkaline range between 8.0 and 9.0,
whereas E. coli DERA which shows a maximal activity
Appl Microbiol Biotechnol
at more neutral pH range (between pH 6–8). Similar to the
E. col i DERA, this mutat ion led to signif icant
improvements in the aceta ldehyde tolerance of
P. atrosepticum DERA.
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Kim et al. (2020) have utilized DERA in synthesis of (R)-1,3-
butanediol (1,3-BDO) which can be used as a precursor for dif-
ferent kinds of polymers and biologically active compounds
(Kim et al. 2020). In this scheme, DERA catalyzes coupling of
two acetaldehydes to form 3-hydroxybutanal which is then re-
duced to 1,3-BDO by aldo-keto reductase. Altogether 20 DERA
aldolases from different organisms were initially screened on the
basis of 1,3-BDO production. DERA BH1352 from Bacillus
halodurans was chosen for further studies and active site muta-
tions based on the solved crystal structure were created. This was
done by targeting hydrophobic residues near the catalytic
Lys155. Mutants were tested for retroaldol reaction by using
DR5P as a substrate and for aldol reaction by following forma-
tion of 1,3-BDO. In retroaldol reaction, Phe160Tyrmutationwas
23% more active compared to B. halodurans DERA wild-type
enzyme. The samemutation increased 1,3-BDO synthesis almost
3-fold. Phe160 is not conserved among DERAs. It corresponds
to Lys172 in E. coli DERA being one of the phosphate-binding
residues. Another B. haloduransDERA variant with double mu-
tation Phe160Tyr/Met173Ile was even more effective. Here the
Met173 corresponds to Met185 in E. coli DERA, where it has
been also been shown to contribute to the sequential aldol con-
densation (Jennewein et al. 2006).
Homologous grafting
Bisterfeld et al. (2016) introduced a term “homologous
grafting” for their protein engineering approach which was
used to engineer the stereoselectivity of E. coli DERA
(Bisterfeld et al. 2016). They utilized the structural informa-
tion from two other E. coli aldolases, namely pyruvate-
dependent 2-keto-3-deoxy-6-phosphogluconate aldolase
(KDPG) and 2-keto-3-deoxy-6-phosphogalactonate aldolase
(KDPGal), to design the mutations. All three aldolases are
TIM barrel proteins and Class I aldolases that utilize
glyceraldehyde-3-phosphate (G3P) as the electrophile. The
two pyruvate-dependent homologous aldolases, which accept
otherwise similar substrates but have different stereospecific-
ities towards one stereogenic carbon, were analyzed using
geometrics and molecular dynamics (MD) simulations as well
as using phylogenetic analysis. This led to the identification of
th ree amino ac id pos i t ions which cou ld a f fec t
stereoselectivity. The corresponding positions in E. coli
DERA (Thr18, Leu20, and Ala203) were then studied by
saturation mutagenesis in two rounds, in terms of enantiomer-
ic excess of aldol reaction using acetaldehyde and propanal as
substrates. Mutations at Thr18 and Leu20 had the largest ef-
fect on stereoselectivity without significant decrease of enzy-
matic activity. It was concluded that Thr18Ser was the most
important residue contributing to stereoselectivity (Bisterfeld
et al. 2016). In the complex structures of wild-type E. coli
DERA (1JCL), the methyl group of Thr18 packs against the
targeted stereogenic carbon which could explain the decrease
in stereoselectivity (Fig. 3B).
Directed evolution of DERA enzymes
In order to improve the applicability of DERA for industrial syn-
thesis of (3R,5S)-6-chloro-2,4,6-trideoxyhexapyranoside, a pre-
cursor for atorvastatin drug, Jennewein et al. utilized various pro-
tein engineering strategies (Jennewein et al. 2006). The desired
reaction couples one chloroacetaldehyde and two acetaldehyde
molecules to form a cyclic hexapyranose which can be further
oxidized to the derivative of mevinic acid, a precursor for
manufacturing of the statin drugs. Directed evolution was used
to improve the resistance of E. coliDERA as well as the catalytic
efficiency towards chloroacetaldehyde. The stability and activity
screenings were carried out initially separately. Stability screening
involved three rounds of mutagenesis and screening, where first a
library with over 20,000 random mutants having 2–5 amino acid
mutations per clone was created. After screening the cell-free ex-
tracts where DR5P retroaldol reaction was assayed in the presence
of chloroacetaldehyde, two rounds of recombination of the best
mutants were carried out. In each case, 3000 clones were screened
in a similar fashion as in the 1st round. This led finally to identi-
fication of four E. coli DERA variants (DERAVar2, DERAVar3,
DERAVar4, and DERAVar5) having substantially improved toler-
ance to chloroacetaldehyde.Here, three amino acid positions could
be identified that affected the stability improvements. The authors
discuss the rational of these mutations based on the solved 3D
structure of E. coli DERA: the residues Phe200, Ile166, and
Met185 together seem to form a small hydrophobic cluster close
to the peptide backbone of the active site Lys167 and Lys201. The
authors also noticed that Lysine residues onE. coliDERAsolvent-
exposed surface were modified upon incubation with
chloroacetaldehyde. Utilization of site-specific mutagenesis of in-
dividual Lysine residues did not, however, lead to a detectable
improvement in chloroacetaldehyde tolerance of the tested variant
DERA variants.
After the chloroacetaldehyde resistance work, Jennewein
and coworkers (Jennewein et al. 2006) used the previously
created random mutant library to screen for improved activity
in an assay set-up where chloroacetaldehyde and acetaldehyde
were used as substrates. This resulted in seven E. coli DERA
variants showing at least 3-fold improvement in product for-
mation compared to the wild-type E. coli DERA (designated
DERA Var6–Var12). The best activity improvement with regard
to (3R,5S)-6-chloro-2,4,6-trideoxyhexapyranoside formation
was obtained with DERAVar9 (having single Phe200Ile sub-
stitution). This substitution led to a reduction in the Km value
(from 55 ± 5 mM to 24 ± 4 mM) for chloroacetaldehyde. The
mutated residue is located in the β-strand of the β-barrel (Fig.
3B). Although the side chain is near the active site, it is
pointing out from the active site and does not directly interact
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with substrate. This mutation may cause small alterations in
the β-barrel structure. In addition, the sequencing of the var-
iants revealed again the importance of the mutations at posi-
tion Met185 (DERAVar11, Met185Thr), similarly to the stabil-
ity mutants. In the end, mutations obtained in the stability and
activity screens were combined. Here in particular, the muta-
tion leading to the Phe200Ile substitution was combined with
mutations affecting the C-terminus, either resulting in the C-
terminal Tyr259 deletion, or its substitution (Tyr259Lys) in
combination with the addition of 9 additional amino acid res-
idues, respectively. These studies showed synergistic action
for the mutations, leading to further improvements of DERA
as a catalyst for the stereoselective synthesis of (3R,5S)-6-
chloro-2,4,6-trideoxyhexapyranoside. The obtained variants
DERAVar13 (Phe200Ile/ΔTyr259) and DERAVar14
(Phe200Ile/Ser258Thr/Tyr259Thr + C-terminal extension
KTQLSCTKW) showed at 500 mM chloroacetaldehyde and
1 M acetaldehyde concentration, 61% and 70% conversion,
r e s p e c t i v e l y , t o ( 3 R , 5 S ) - 6 - c h l o r o - 2 , 4 , 6 -
trideoxyhexapyranoside after 8 h. In contrast with wild-type
DERA, only a minor amount of product was obtained under
similar conditions.
Jiao et al. (2017) have used random mutagenesis to im-
prove the catalytic efficiency of Lactobacillus brevis DERA
in sequential aldol reaction in synthesis of (3R,5S)-6-chloro-
2,4,6-trideoxyhexapyranoside (Jiao et al. 2017). Altogether
2000 clones were tested by assaying reaction mixture contain-
ing chloroacetaldehyde and acetaldehyde. The reaction mix-
ture contained also Lodderomyces elongisporus aldehyde de-
hydrogenase which oxidized the aldol product to the corre-
sponding lactone. Two mutants, Thr29Val and Thr29Leu,
showed improved activities. Thr29 (corresponding to Leu32
in E. coli DERA, Fig. 3B) is located in an alpha helix, and the
side chain is located on the interface between the β-barrel and
the α-helix. Its substitution may thus cause only a minor
change in the shape of the active site. Additional mutations
were subsequently searched for the Thr29Leu variant by
targeting the loops of the active site. Although higher activi-
ties were found, for example, for the mutant Thr29Leu/
Phe163Tyr, the original single mutation Thr29Leu produced
a higher yield for the product in a shorter time, probably be-
cause of its better tolerance at high aldehyde concentrations.
Machine learning (ML)–guided protein
engineering
Machine learning (ML)models can predict how an amino acid
sequence correlates to protein function in a data-driven man-
ner, independently of the 3D structure. These methods have a
potential to accelerate directed evolution by reducing the num-
ber of variants and evolution cycles, as they can learn from the
properties of characterized enzyme variants and use that
information to select sequences that are likely to exhibit im-
proved properties (Fig. 4). It is also worth noting that the ML-
based methods are not iterative as in classical directed evolu-
tion, but they can also generate new, previously unseen vari-
ants with promising properties. There are several recent re-
view articles on how machine learning can be used to guide
the directed evolution (Yang et al. 2019; Mazurenko et al.
2020; Wittmann et al. 2021).
Voutilainen et al. have recently used three rounds of muta-
genesis combined with a ML method to create variants of
E. coliDERA having improved catalytic activity for acetalde-
hyde aldol reaction, combined with clearly reduced activity
for DR5P and DR retroaldol reaction (Voutilainen et al. 2020).
At first round, 69 single DERAmutants were created targeting
24 amino acid positions selected mainly by using 3D struc-
tures, literature data, and bioinformatics tools, such as Hotspot
Wizard (Bendl et al. 2016). The catalytic properties of the
mutants were tested in three different reactions: to retroaldol
direction by using DR5P and DR as substrates and aldol di-
rection by using acetaldehyde as a single substrate. Five mu-
tants (Gly204Ala, Ser239Glu, Leu17Gly, Gly171Ala, and
Gly171Ser) showed increased activity for the aldol reaction,
and reduced activity for the retroaldol reaction towards DR5P.
In the second round, 62 variants containing two or three amino
acid mutations were tested. The additional mutant positions
were selected either manually by utilizing data from the pre-
vious round or by using saturation mutagenesis on selected
positions. A number of variants were found showing reduced
retroaldol activity towards DR5P and DR as well as improved
aldol activity towards acetaldehyde.
The results from the first and second round contained bio-
chemical characterization and sequence data for 131 E. coli
DERA variants, which was used to train the ML model to
automatically predict all three substrate specificities (on
DR5P, DR, and acetaldehyde) (Voutilainen et al. 2020).
Altogether 48,000 new E. coli DERA variants having 1–3
amino acid mutations were then created and screened in silico.
From 50 top DERA variants having highest aldol activity on
acetaldehyde and low retroaldol activity towards DR5P, 18
E. coli DERA mutants were finally expressed, purified, and
tested. All had minimal activity towards DR5P and DR but
improved activity in acetaldehyde aldol reaction, thus demon-
strating the power of computer-aided tools in protein engi-
neering. Five best DERA variants had more than twofold im-
proved activity towards acetaldehyde: Cys47Val/Gly204Ala/
Ser239Asp, Asn21Ser/Cys47Glu/Gly204Ala, Cys47Val/
Gly204Ala/Ser239Glu, Cys47Val/Gly204Ala, and
Asn21Lys/Cys47Val/Gly204Ala (Table 2). When consider-
ing all the mutant data created in this work, many beneficial
mutant positions are in the substrate-binding site where the
phosphate group of DR5P binds (namely Gly171, Gly204,
Ser238, Ser239, Asn21). Some of these mutations were
shown to cause conformational changes in the substrate-
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binding site, narrowing the entrance. Creating negative charge
near the phosphate-binding site, e.g. through Ser239Asp mu-
tation, also likely contributed to the decreased phosphate bind-
ing. All the best DERA variants included also mutation at
Cys47, which has been shown also in other studies to be a
beneficial target for substitutions, probably due to decreased
covalent inhibitory adduct formation with aldehydes
(Voutilainen et al. 2020). The DERA from a hyperthermophil-
ic A. pernix has naturally a Valine residue at this position.
Other means to improve DERA properties
for application purposes
Enzyme immobilization on solid support is often used in appli-
cations, as it facilitates separation, may be reused, and permits
continuous operation. The drawback is that the immobilization
may lower the specific activity of the enzyme, e.g. due to steric
hindrances. However, there are also reports that through immo-
bilization improved enzyme properties can be obtained. Thus,
immobilization may act in some cases as an alternative or ad-
ditional approach to protein engineering. As an example, E. coli
DERA has been immobilized on multiwalled carbon nano-
tubes, and the catalytic performance was evaluated in the self-
aldol reaction of acetaldehyde and using chloroacetaldehyde.
DERA in immobilized form was shown to exhibit tolerance
to higher acetaldehyde concentration and the enzyme activity
wasmaintained after five cycles (Subrizi et al. 2014). Stable and
efficient enzyme immobilization technique could also be
established by immobilizing E. coli DERA on glutaralde-
hyde-(3-aminopropyl)triethoxysilane nano-magnet material
(GA-APTES-NSM). Over 75% of the applied enzyme was
immobilized and an increase in tolerance to higher substrate
concentrations was observed. Immobilized enzyme also exhib-
ited enhanced thermal stability (Fei et al. 2014). In addition to
nanomaterials as immobilization matrix, E. coliDERA has also
been immobilized on thin polymeric films (Zhang et al. 2018;
2019). The conjugation of the synthetic polymer to DERA led
to increased acetaldehyde tolerance of the enzyme (Zhang
2018). In addition, crosslinking of the DERA-polymer onto a
polymeric membrane support allowed the active membrane to
be tested in a continuous-flow mode process. Low amounts of
aldol product could be observed using hexanal and acetalde-
hyde as substrates (Zhang et al. 2019). A continuous-flow pro-
cess was also developed by Grabner et al. for the synthesis of
statin side-chain precursor. In this process, freeze-dried whole
E. coli cells expressing the C47M DERA mutant were
immobilized using alginate-luffa matrix (Grabner et al. 2020).
Besides immobilization, the use of whole cell biocatalysts
is an attractive alternative in industrial processes, not only due
to the low production cost, but also as a tool to stabilize the
enzymes (Lin and Tao 2017). E. coli cells overexpressing
E. coli DERA have been used as a whole cell biocatalyst to
produce, e.g., lactonized side-chain intermediates used in stat-
in synthesis (Ošlaj et al. 2013).When the bacterial cells from a
fed-batch, high-density bioreactor cultivation were used, the
DERA-catalyzed sequential aldol addition reaction of acetal-
dehyde was shown to be highly productive and cost-efficient
with products having high enantiomeric purities (Ošlaj et al.
2013). In another study by Feron et al. (2007) E. coli cells
overexpressing E. coli DERA were used to produce 4-
hydroxybenzylidene acetone, a precursor of raspberry ketone
which is the key component of raspberry flavour. DERA cat-
alyzed an aldol reaction between 4-hydroxybenzaldehyde and
acetone to produce 4-hydroxybenzylidene acetone. An advan-
tage of this process was that the bacterium also catalyzed the
beta-elimination of water from the direct product of the aldol
reaction, thus preventing further reactions to take place (Feron
et al. 2007). In a third example, higher substrate tolerance and
increased product yield were achieved when E. coli cells
Fig. 4 A schematic picture how machine learning (ML) methods can be
applied to accelerate protein engineering work.MLmodels can be trained
from a relatively limited set of experimental variant data to predict how
amino acid sequence maps to function without requiring information
about the 3D protein structure. The ML models can be used to predict
the properties of variants not experimentally evaluated and to propose a
new, limited set of experimental variants to be screened in the next
evolution round in order to improve the protein properties
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overexpressing a mutatedKlebsiella pneumoniaeDERAwere
used for the biosynthesis of D-2-deoxyribose from D-
glyceraldehyde and acetaldehyde as compared to in vitro en-
zymatic synthesis (Li et al. 2015). As also mentioned earlier,
the mutated KDERAK12 (K. pneumoniae DERA Ser238Asp/
Phe200Ile/ΔTyr259) enzyme showed in vitro 3 times higher
specific activity and 1.5-fold increased substrate tolerance as
compared to the wild-type enzyme. By using whole cell bio-
catalysis approach, the substrate (aldehyde) tolerance of
KDERAK12 could be further improved (from 0.5 M to 3 M)
(Li et al. 2015).
Multistep enzyme cascades in vitro
and in vivo
Besides single-enzyme catalyzed reactions, DERA aldolases
have also been applied in vitro and in vivo in sequential bio-
catalytic reactions. Multi-enzyme cascades avoid the waste
generated by purification of intermediates and they also allow
reactions to be linked together to overcome an unfavourable
equilibrium, or avoid the accumulation of unstable or inhibi-
tory intermediates. Furthermore, in the case of microbial path-
ways (in vivo enzyme cascades), diverse new compounds can
be synthetized directly from renewable sources.
As a proof-of-concept, DERA-based pathway has been
engineered in E. coli cells to produce 1,3-BDO from glucose,
involving three heterologous enzymes: pyruvate decarboxyl-
ase (PDC, producing acetaldehyde from pyruvate), DERA
(catalyzing aldol addition of two acetaldehyde molecules to
3-hydroxybutanal), and aldo-keto reductase (AKR), which re-
duces 3-hydroxybutanal (3-HB) to 1,3-BDO (Nemr et al.
2018). The product titer and yield were further improved
using metabolic engineering approaches, which included re-
ducing major by-products and increasing pathway flux
through DERA to reduce accumulation of toxic acetaldehyde,
as well as implementing a two-stage fermentation process. As
a follow-up of this work, Kim et al. (2020) screened 20 mi-
crobial DERAs for the most potent enzyme on acetaldehyde
addition reaction and identified Bacillus haloduransDERA as
a potent aldolase for production of 1,3-BDO from acetalde-
hyde. As also described above, structure-based site-directed
mutagenesis was further used to create B. halodurans DERA
variants with higher activity in the production of 1,3-BDO.
The replacement of the wild-type DERA by the Phe160Tyr or
Phe160Tyr/Met173Ile variants in E. coli cells expressing the
DERA+AKR pathway increased the production of 1,3-BDO
from glucose five and six times, respectively.
Several research groups have utilized DERA enzyme in
combination with other enzymes in in vitro synthesis studies.
Horinouchi et al. (2006) coupled Klebsiella pneumoniae
DERA as a last step in synthesis of DRP from D-glucose by
utilizing first the glycolytic enzymes of baker’s yeast
(S. cerevisiae) to produce fructose 1,6-diphosphate that was
then used by the DERA-expressing E. coli cells. Honda and
coworkers (Honda et al. 2010) used DERA and five other
thermophilic enzymes from T. thermophilus in a multi-
enzyme cascade to produce DRP from fructose with a high
yield. Furthermore, van Herk et al. (2009) tested a two-
enzyme cascade reaction consisting of the Val78Leu mutant
of a non-specific acid phosphatase and DERA to produce
DRP from DL-glyceraldehyde. As a last example, a multi-
enzyme cascade has recently been used in vitro to construct
investigational Islatravir drug for HIV treatment from simple
building blocks in a collaborative effort by Merck and
Codexis (Huffman et al. 2019). The overall biocatalytic syn-
thesis route required clearly less steps than the previously
reported routes. For this cascade, the Shewanella halifaxensis
DERAwas chosen based on its high activity, stereoselectivity
(> 99% de), and kinetic selectivity favouring reaction with
(R)-enantiomer of the aldehyde. Two rounds of directed evo-
lution were carried out to obtain a S. halifaxensis DERA var-
iant that retained high activity at an acetaldehyde concentra-
tion > 400 mM. This variant contained altogether 11 amino
acid changes (Ser2Cys; Gln10Arg; Cys47Val; Asp66Leu;
Ala71Val; Ala145Lys; Leu156Ile; Met184Ile; Val203Ile;
Ser235Thr; Ser236Asp), including also the mutation at the
Cys47, shown also by others to affect the acetaldehyde
inhibition.
Conclusions and future perspectives
DERA is a potential industrial biocatalyst for C–C bond forma-
tion reactions. There are already many examples where DERA
has been utilized in stereoselective enzyme-assisted synthesis of
commodity chemicals, flavours, and building blocks for pharma-
ceutical drug molecules. Different protein engineering ap-
proaches have also been successfully used in improving the sub-
strate specificity, catalytic efficiency, and lifetime towards native
and non-native substrates and reactions. These studies demon-
strate that the TIM barrel fold of DERA aldolases offers a good
starting point to develop novel biocatalysts. Many of the studies
have been carried out using E. coli DERA; however, there are a
multitude of other DERA enzymes that would also offer a good
starting point for protein engineering and usage as a biocatalyst in
various applications. As there is a requirement for moving to-
wards more sustainable future, we should be able to create faster
and more efficient biocatalysts to produce completely new type
of products. The successful design of optimal biocatalysts re-
quires not only use of advanced protein engineering strategies,
but it would greatly benefit of having more high-accuracy bio-
chemical data available, particularly involving data on enzyme
kinetics and product analysis. There is currently a huge amount
of gene sequencing data available, but the biochemical
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characterization of enzymes is lacking behind, thus hindering the
realization of the full potential of data-driven computational
tools.
Concerning future perspectives, the most extreme case of
protein engineering is de novo protein design, where
completely non-natural proteins are designed “from scratch”
based purely on biophysical principles (Jiang et al. 2008;
Huang et al. 2016). Here the challenge is to identify a protein
sequence that will fold into a desired structure and function.
Protein modelling software, such as Rosetta (Rohl et al. 2004;
Alford et al. 2017), is an indispensable tool for screening in
silico sequence candidates for a desired fold. The kinetic pa-
rameters of de novo designed enzymes are still clearly lower
than those of naturally occurring ones, but here again directed
evolution can be utilized to improve the properties. As an
example of these types of efforts, E. coli DERA TIM barrel
scaffold has been utilized to create an artificial enzyme that
can carry out an unnatural reaction, named as Kemp elimina-
tion (Khersonsky et al. 2011). Furthermore, the recent devel-
opment in artificial intelligence (AI)–based approaches, such
as the AlphaFold (Callaway 2020) that can be used for deter-
mining a protein’s 3D structure from its amino acid sequence,
is expected to further speed up the progress.
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